Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone for Depression with Childhood Trauma
NCT05217758Phase 2Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2021
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mifepristone in major depressive disorder (MDD), sponsored by Amsterdam University Medical Center. Started Dec 2021; status: completed.
02
Drugs
mifepristone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05217758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05217758.